Eliminating resilient cancer stem cells through precision targeted therapies in solid tumours.
all companies
milestones
Founded 2008
Partnered 2011
Acquired (AbbVie) 2016
Team
Scott Dylla
Dan Reiner
Brian Slingerland
Board
Stuart Peterson
LEAD INVESTOR
category
Oncology
Combining scientific talent from the world’s leading academic labs and enterprises, a stem cell-centric philosophy and an approach that embraces new technologies and paradigms to discover and develop novel therapies and diagnostics for patients with solid tumors
No items found.
